Moderna Covid-19 vaccine trial shows 94.1 per cent efficacy: Study
NEW YORK: US-based biotechnology company Moderna’s Covid-19 vaccine demonstrated 94.1 per cent efficacy, showed results from the primary analysis of a phase-3 trial. The study, published in The New England Journal of Medicine, provides evidence that the vaccine, mRNA-1273, can prevent symptomatic infection. The results are similar to the first interim analysis of the study […]